仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000650 仁和药业

已收盘 05-11 15:00:00

{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":5.76,"timestamp":1778482995000,"preClose":5.71,"halted":0,"volume":18367230,"delay":0,"changeRate":0.0088,"floatShares":1331000000,"shares":1400000000,"eps":0.2638,"marketStatus":"已收盘","change":0.05,"latestTime":"05-11 15:00:00","open":5.73,"high":5.78,"low":5.68,"amount":105000000,"amplitude":0.0175,"askPrice":5.77,"askSize":804,"bidPrice":5.76,"bidSize":1962,"shortable":0,"etf":0,"ttmEps":0.2638,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778549400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.71,"symbolType":"stock","openAndCloseTimeList":[[1778463000000,1778470200000],[1778475600000,1778482800000]],"highLimit":6.28,"lowLimit":5.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"isCdr":false,"pbRate":1.24,"roa":"--","peRate":21.834723,"roe":"2.2%","epsLYR":0.28,"committee":-0.153095,"marketValue":8064000000,"turnoverRate":0.0138,"status":0,"floatMarketCap":7669000000},"requestUrl":"/m/hq/s/000650/tweets","defaultTab":"tweets","newsList":[{"id":"2634442550","title":"股市必读：仁和药业（000650）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634442550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634442550?lang=zh_cn&edition=full","pubTime":"2026-05-11 01:54","pubTimestamp":1778435653,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，仁和药业报收于5.71元，上涨0.35%，换手率0.96%，成交量12.84万手，成交额7333.44万元。中药经典名方二冬汤颗粒未参与2025年医保谈判，已有销售但利润贡献有限。二冬汤颗粒为公司首个获批的经典名方产品，具体获批时间依国家药监局审评进度而定。医药OTC行业处于2025年深度调整、2026年筑底企稳的过渡期。2026年一季度公司营收同比增长14.57%，扣非净利润增长33.20%，主因药品主业利润贡献上升，从上年同期1.02亿元增至1.36亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100000913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633173193","title":"股市必读：仁和药业（000650）5月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633173193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633173193?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:22","pubTimestamp":1778181732,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，仁和药业报收于5.69元，上涨0.0%，换手率1.09%，成交量14.53万手，成交额8267.24万元。关于参加江西辖区上市公司2026年投资者网上集体接待日活动的公告仁和药业股份有限公司将参加由江西省上市公司协会举办的2026年江西辖区上市公司投资者网上集体接待日活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800003567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608175","title":"每周股票复盘：仁和药业（000650）股东户数下降3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608175?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:32","pubTimestamp":1777768331,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，仁和药业报收于5.69元，较上周的5.55元上涨2.52%。本周，仁和药业4月28日盘中最高价报5.78元。业绩披露要点：仁和药业2026年一季报显示，扣非净利润1.36亿元，同比上升33.2%。股本股东变化股东户数变动截至2026年4月20日，仁和药业股东户数为9.2万户，较3月31日减少2994.0户，减幅为3.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630068303","title":"仁和药业（000650）披露以集中竞价交易方式回购股份的回购报告书，4月28日股价上涨2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630068303","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630068303?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:23","pubTimestamp":1777375381,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，仁和药业报收于5.72元，较前一交易日上涨2.88%，最新总市值为80.08亿元。仁和药业于近日披露《公司关于以集中竞价交易方式回购股份的回购报告书》。公告显示，公司拟使用自有资金以集中竞价交易方式回购公司股份，回购资金总额不低于8,000.00万元且不超过15,000.00万元，回购价格不超过8.00元/股。本次回购股份拟用于后续实施股权激励或员工持股计划。预计回购股份数量约为1,000.00万股至1,875.00万股，占公司总股本比例0.71%至1.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800055308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630946367","title":"图解仁和药业一季报：第一季度单季净利润同比下降14.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630946367","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630946367?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:19","pubTimestamp":1777285188,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业2026年一季报显示，一季度公司主营收入11.29亿元，同比上升14.57%；归母净利润1.4亿元，同比下降14.57%；扣非净利润1.36亿元，同比上升33.2%；负债率10.38%，投资收益549.85万元，财务费用-53.8万元，毛利率36.7%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700034078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630657733","title":"仁和药业：公司有自己生产和销售的益生菌类产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2630657733","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630657733?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:21","pubTimestamp":1777278077,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问公司益生菌产品是自产还是代工？B420等菌株的销售情况如何？有没有瘦身减肥的功效？仁和药业回复：尊敬的投资者您好，公司有自己生产和销售的益生菌类产品。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700028841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630836510","title":"仁和药业：公司2021年6月，与北京洛必德科技有限公司签订了增资协议，支付投资款人民币1000万元，持股比例1.5365%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630836510","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630836510?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:12","pubTimestamp":1777277533,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！公司投资洛必德机器人是几年前的事了，证明公司的长远发展眼光非常独到，如果洛必德上市，公司就是直接受益者仁和药业回复：尊敬的投资者您好，公司2021年6月，与北京洛必德科技有限公司签订了增资协议，支付投资款人民币1000万元，持股比例1.5365%。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700027995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","CYB","CNHmain","MUCmain","UCmain","MCNHmain","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630046331","title":"股市必读：仁和药业年报 - 第四季度单季净利润同比下降78.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630046331","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630046331?lang=zh_cn&edition=full","pubTime":"2026-04-27 06:41","pubTimestamp":1777243268,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，仁和药业报收于5.55元，下跌2.8%，换手率1.8%，成交量24.01万手，成交额1.33亿元。股本股东变化股东户数变动近日仁和药业披露，截至2026年4月20日公司股东户数为9.2万户，较3月31日减少2994.0户，减幅为3.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700006756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629814937","title":"仁和药业(000650)4月20日股东户数9.2万户，较上期减少3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629814937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629814937?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:32","pubTimestamp":1777023154,"startTime":"0","endTime":"0","summary":"证券之星消息，近日仁和药业披露，截至2026年4月20日公司股东户数为9.2万户，较3月31日减少2994.0户，减幅为3.15%。在中药行业个股中，仁和药业股东户数高于行业平均水平，截至4月20日，中药行业平均股东户数为5.31万户。从股价来看，2026年3月31日至2026年4月20日，仁和药业区间涨幅为0.52%，在此期间股东户数减少2994.0户，减幅为3.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400052720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629549938","title":"图解仁和药业年报：第四季度单季净利润同比下降78.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629549938","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629549938?lang=zh_cn&edition=full","pubTime":"2026-04-24 01:51","pubTimestamp":1776966660,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业2025年年报显示，当年度公司主营收入35.36亿元，同比下降13.21%；归母净利润3.93亿元，同比下降18.41%；扣非净利润2.49亿元，同比下降25.51%；其中2025年第四季度，公司单季度主营收入7.03亿元，同比下降23.94%；单季度归母净利润1407.29万元，同比下降78.75%；单季度扣非净利润-2765.32万元，同比下降187.29%；负债率10.38%，投资收益8343.0万元，财务费用39.29万元，毛利率36.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400004552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629005998","title":"仁和药业：截至2026年4月20日，大约9.2万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2629005998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629005998?lang=zh_cn&edition=full","pubTime":"2026-04-23 11:36","pubTimestamp":1776915392,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：截至4月20号的股东人数为多少仁和药业回复：谢谢您的关注，截至2026年4月20日，大约9.2万户左右。具体数据，根据相关法规，请您先向公司证券部提交股东身份证明，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300031544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628793467","title":"股市必读：仁和药业（000650）4月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2628793467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628793467?lang=zh_cn&edition=full","pubTime":"2026-04-20 03:00","pubTimestamp":1776625235,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，仁和药业报收于5.8元，下跌1.53%，换手率0.94%，成交量12.53万手，成交额7282.26万元。董秘最新回复投资者： 请问哈药股份的药妆业务在去年与董宇辉合作后实现跨越式的增长，今年预计营收破10亿。有报道指出，在苏国辉院士团队的带领下，必爱智能与贵公司的脑机接口眼镜方案已在广州脑科医院、深圳康宁医院等40余家三甲医院落地，服务了超3000例患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628735072","title":"仁和药业：是3000多例用户的科研数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2628735072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628735072?lang=zh_cn&edition=full","pubTime":"2026-04-17 15:03","pubTimestamp":1776409389,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业04月17日在投资者关系平台上答复投资者关心的问题。根据2025年中国国际福祉博览会的必爱智能的企业宣传材料明确指出：在苏国辉院士团队的合作背书下，必爱智能与贵司的脑机接口眼镜方案已在广州脑科医院、深圳康宁医院等40余家三甲医院落地，服务了超3000例患者。请问，这个3000例真实脑机接口智能眼镜服务案例的报道属实吗？据证券部了解，是3000多例用户的科研数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700023066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624052410","title":"仁和药业：公司有相关减肥类产品销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2624052410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624052410?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:34","pubTimestamp":1775100889,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，你好。请问贵公司是否生产和销售减肥药类产品？仁和药业回复：尊敬的投资者，您好！公司有相关减肥类产品销售。具体请您致电公司400全国客服号咨询。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200015086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624463524","title":"仁和药业：目前公司没有与上述公司合作过","url":"https://stock-news.laohu8.com/highlight/detail?id=2624463524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624463524?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:34","pubTimestamp":1775100881,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：1. 药石科技在分子砌块、连续流工艺、ADC/TPD关键中间体等领域具备国内独一档的技术壁垒，也是很多创新药公司早期研发和CMC开发的重要合作伙伴。请问贵司在管线研发中，是否与药石科技有合作？未来是否有计划在早期化合物发现、工艺开发或商业化生产层面开展合作？仁和药业回复：尊敬的投资者，您好！目前公司没有与上述公司合作过。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200015076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621136083","title":"股市必读：仁和药业（000650）3月23日收盘跌5.65%，主力净流出2313.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621136083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621136083?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:33","pubTimestamp":1774287190,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，仁和药业报收于5.34元，下跌5.65%，换手率2.38%，成交量31.72万手，成交额1.72亿元。交易信息汇总股价提醒3月23日仁和药业收盘报5.34元，跌5.65%，当日成交3171.75万元。根据收盘数据统计，该股已连续3日下跌。前10个交易日资金流向情况：主力资金累计净流出1.03亿元，股价累计下跌8.58%；融资余额累计减少1310.9万元，融券余量累计减少3.42万股。资金流向3月23日主力资金净流出2313.72万元；游资资金净流入733.9万元；散户资金净流入1579.82万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618968865","title":"股市必读：仁和药业（000650）3月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618968865","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618968865?lang=zh_cn&edition=full","pubTime":"2026-03-11 01:43","pubTimestamp":1773164592,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，仁和药业报收于5.91元，上涨0.51%，换手率1.0%，成交量13.35万手，成交额7882.72万元。董秘最新回复投资者： 你好 ，董秘！首先公司400全国客服电话周一至周五正常上班时间全是人工接听，非机器人电话。其次，正常的商业行为，建议您咨询相关售货平台。交易信息汇总资金流向3月10日主力资金净流出590.84万元；游资资金净流出432.2万元；散户资金净流入1023.04万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100000775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616440368","title":"股市必读：仁和药业（000650）3月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616440368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616440368?lang=zh_cn&edition=full","pubTime":"2026-03-03 02:55","pubTimestamp":1772477711,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，仁和药业报收于5.92元，下跌1.66%，换手率1.54%，成交量20.45万手，成交额1.21亿元。董秘最新回复投资者： 公司砍掉缩减募投项目，是否说明产品卖不动了，现有各产品线产能利用率情况如何？董秘： 尊敬的投资者，关于募投项目调整及终止的详细情况请查阅公司2025-045号公告，谢谢！当日关注点来自交易信息汇总：3月2日主力资金净流出163.41万元，游资资金净流入309.15万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300001611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614060891","title":"仁和药业：公司有生产和销售多款抗病毒药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2614060891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614060891?lang=zh_cn&edition=full","pubTime":"2026-02-26 11:36","pubTimestamp":1772076968,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业02月25日在投资者关系平台上答复投资者关心的问题。据日本官方发布的通报截至今年 2月15日的这一周全国定点医疗机构 报告的流感病例数接近 16万例。目前已有超过8000所学校停课。并且专家提醒流感或持续到三四月份 ，而且存在二次感染风险。药房的抗病毒药物多脱销，居民大量囤积口罩消毒水和 抗病毒药物。谢仁和药业回复：谢谢您的关注！公司有生产和销售多款抗病毒药品，详细请查阅公司官网或子公司官网。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600014185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614067296","title":"仁和药业：公司ULOOK眼镜尚在销售测试和改进阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2614067296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614067296?lang=zh_cn&edition=full","pubTime":"2026-02-26 11:30","pubTimestamp":1772076625,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有没有ulook眼睛脑机眼镜的项目吗，不要老是用模棱两可的话，说这个不知道那个不了解，有没有这个项目，应该你们有义务知道吧，应该不会是编造出来的骗我们小散接盘的项目吧仁和药业回复：尊敬的投资者您好：公司ULOOK眼镜尚在销售测试和改进阶段。此类问题已在前期互动易平台回复过，请您仔细查阅相关回复，谢谢您的关注和支持!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600013721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778492789462,"stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0355},{"period":"3month","weight":-0.0403},{"period":"6month","weight":-0.0879},{"period":"1year","weight":0.0827},{"period":"ytd","weight":0.0106}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仁和药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"92000人(较上一季度减少3.15%)","perCapita":"14471股","listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","registeredCapital":"139993万元","survey":"　　仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。","listedPrice":6.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}